Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Alemtuzumab 3-year data show durable effect on MS disability
Structure and signalling in the IL-17 receptor family.
Warner Chilcott sells Vectrin product line to Medicis
Dalfampridine Improves Sensorimotor Function in Rats With Chronic Deficits After Middle Cerebral Artery Occlusion.
Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
Preventive healthcare use among males with multiple sclerosis.
Multiple sclerosis.
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes.
Ustekinumab approved for psoriatic arthritis in US, Europe
Cyclophosphamide so-so verdict in progressive MS
Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
Clinical analysis of the etiology of optic neuritis in patients at different ages in china.
Activation of Invariant NKT Cells in Early Phase of Experimental Autoimmune Encephalomyelitis Results in Differentiation of Ly6Chi Inflammatory Monocyte to M2 Macrophages and Improved Outcome.
Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
The genetic and environmental bases of complex human-disease: extending the utility of twin-studies.
CD44 is required for the migration of transplanted oligodendrocyte progenitor cells to focal inflammatory demyelinating lesions in the spinal cord.
In Vivo Brain MR Imaging at Subnanoliter Resolution: Contrast and Histology.
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.
Riluzole increases glutamate uptake by cultured C6 astroglial cells.
Secukinumab shines in small MS trial
Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme.
Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis.
Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis.
Complex molecular and functional outcomes of single versus sequential cytokine stimulation of rat microglia.
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.
Pages
« first
‹ previous
…
159
160
161
162
163
164
165
166
167
…
next ›
last »